Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143
Clinical trial NCT04122625 · COMPLETED
Trial details
- NCT number
- NCT04122625
- Sponsor
- Debiopharm International SA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2022-04-06
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.